Timing of Access Closure in Transfemoral Impella Care

INTERVENTION: Group 1: 50 patients with deployment of the suture‐based vascular closure system already at the time of Impella implantation Group 2: 50 patients with deployment of the suture‐based vascular closure system only at the time of Impella explantation. CONDITION: ; R57.0 Cardiogenic shock PRIMARY OUTCOME: Composite endpoint of bleeding events =BARC 3a, vascular and access‐site‐related complications excluding bleeding, and 30‐day all‐cause mortality SECONDARY OUTCOME: ‐ Life‐threatening bleeding events (BARC 3b/5) ; ‐ Major bleeding events (BARC 3a) ; ‐ Major vascular and access‐site‐related complications, excluding bleeding ; ‐ Minor vascular and access‐site‐related complications, excluding bleeding ; ‐ Need for transfusion ; ‐ Length of hospital stay ; ‐ 30‐day all‐cause mortality INCLUSION CRITERIA: Transfemoral Impella implantation